Johnson & Johnson kicks off study of single-shot COVID-19 vaccine
The company expects results of the Phase III trial by year end or early next year.
Full Article
Johnson & Johnson kicks off study of single-shot COVID-19 vaccine
Hindu
0 shares
1 views
You might like
Related news coverage
COVID-19: Two lakh dead as Donald Trump vilifies science
Mid-Day
"I did the best I could," President Donald Trump said. Huddled with aides in the West Wing last week, his eyes fixed on Fox News,..
-
The Latest: China lifts pandemic bar on entry by foreigners
SeattlePI.com
-
Coronavirus vaccine study enters fina...
Express and Star
-
JNJ Begins Phase 3 COVID-19 Vaccine Trial, Another Headstone In Alzheimer's Graveyard, PFE On Watch
RTTNews
-
Johnson & Johnson (NYSE:JNJ) starts late-stage coronavirus vaccine clinical trial
Motley Fool
Advertisement
More coverage
Johnson & Johnson begins final-stage testing on single-dose COVID-19 vaccine
WorldNews
Johnson & Johnson is beginning a huge final study to try to prove if a single-dose COVID-19 vaccine can protect against the virus...
-
Nike, Western Digital rise; Stitch Fix, Steelcase fall
SeattlePI.com
-
Johnson & Johnson Starts Late-Stage Coronavirus Vaccine Clinical Trial
Motley Fool
-
Late-stage study of first single-shot coronavirus vaccine begins in U.S.
Denver Post
-
Johnson & Johnson begins final phase of single-shot COVID-19 vaccine study
CBC.ca